BAIBYS Fertility News
3 articles
growth-positive
BAIBYS raises $4.5M Series A for AI-based system that selects ideal sperm for fertility treatments | CTech
Israeli startup BAIBYS, which has developed an AI-based system for selecting ideal sperm for fertility treatments, has raised $4.5 million in a Series A funding round. The round was led by Firstime Ventures and included participation from Japanese pharmaceutical giant ROHTO. The funding will be used to begin sales of the system this year. BAIBYS system examines sperm samples and automatically selects ideal sperm according to WHO criteria, aiming to improve treatment success rates and reduce birth defects. The company has raised a total of $6.5 million to date.
InvestmentExpand
growth-positive
BAIBYS Fertility: Improving the systems for IVF and reproduction | CTech
BAIBYS Fertility, a medical device company that develops an AI and robotics-based autonomous system for sperm selection for IVF, has raised $4.2 million to date. The company aims to improve success rates, reduce birth defects, and increase clinics throughput. The investors include 14 angles, who are IVF experts and clinic owners, and Firstime VC. BAIBYS Fertility was part of the Israeli startup squad that participated in Calcalists Israel-Japan 2023 conference, where they presented their company to senior executives from the Japanese and international tech industries.
Investment
growth-positive
יוצאת מהגראז': בייביז משתמשת ב-AI כדי למצוא זרעון...
Israeli start-up BAIBYS, founded by Gal Golub, is using artificial intelligence to improve the process of identifying healthy sperm for in-vitro fertilisation (IVF). The technology, which is currently in the prototype stage, is able to complete a process that takes embryologists three hours in just 15 minutes, significantly reducing costs. The company was founded in March 2020 and has raised $4 million in funding to date, with investors including Dr. Nino Guy Cassuto and Firstime.
InvestmentExpand